By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synairgen plc 

Mailpoint 810, Level F - South Block
Tremona Road
Southampton    SO16 6YD  United Kingdom
Phone: 44-0-23-8051-2800 Fax:



Drug Discovery

Company News
Synairgen (SNG.L): Additional Positive Data In Lung Fibrosis 3/10/2017 9:20:49 AM
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial 10/12/2016 5:41:58 AM
Synairgen plc Release: Preliminary Statement Of Results For The Year Ended 31 December 2015 3/22/2016 9:26:47 AM
Synairgen plc Release: Positive LOXL2 Results 3/22/2016 9:19:20 AM
Pharmaxis (PXS.AX) And Synairgen plc Announce Research Collaboration To Develop LOXL2 Inhibitor For Pulmonary Fibrosis 8/5/2015 6:29:49 AM
Synairgen plc Interim Results For The Six Months Ended 30 June 2014 9/25/2014 1:24:57 PM
Synairgen plc Release: Notice Of Interim Results 9/17/2014 10:31:52 AM
AstraZeneca PLC (AZN) Beefs Up Pipeline With $232 Million Synairgen plc Asthma Deal 6/12/2014 6:14:25 AM
Synairgen plc in Drug Partnership Talks After Study Results 9/5/2012 8:14:11 AM
Synairgen plc: New Research Signals Second Indication For Interferon Beta Programme In COPD 5/24/2006 11:16:06 AM